Navigation Links
Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences
Date:5/11/2011

LEXINGTON, Ky., and MOUNTAIN VIEW, Calif., May 11, 2011 /PRNewswire/ -- Transposagen Biopharmaceuticals, Inc. (Transposagen) and System Biosciences (SBI), both leaders in genetic modification technology, have announced a non-exclusive marketing and distribution agreement between the two biotechnology companies involving Transposagen's piggyBac™ technology.

The piggyBac Genetic Modification System enables researchers to:

  • Alter the genomes of numerous animal species with a simple transfection
  • Reprogram somatic cells into induced pluripotent stem (iPS) cells
  • Perform highly efficient and cost-effective non-viral gene delivery
  • Reverse genomic modifications with footprint-free transposon removal

  • The piggyBac DNA transposon technology is already being utilized in multiple research areas, such as gene therapy, regenerative medicine, cell line engineering, and animal model creation. "We are excited to add the world's most efficient and cost-effective non-viral reprogramming technology to our already impressive catalog of stem cell and microRNA research reagents," said Dr. Travis Antes, the Director of Product Development at SBI.  

    (Logo: http://photos.prnewswire.com/prnh/20110511/CL00173LOGO)

    Researchers in academia and the pharmaceutical and biotechnology industries can now purchase piggyBac™ vectors produced with SBI's high standards of manufacturing and quality control. Transposagen's piggyBac™ technology will be paired with SBI's existing leading-edge technologies to further broaden the utility of piggyBac™. SBI will also use piggyBac™ in custom vectors and cell lines for customers. Furthermore, Transposagen and SBI have agreed to collaborate in the production of custom transgenic rats. The collaboration will combine SBI's genomic tools and expertise with Transposagen's piggyBac and rat spermatogonial stem cell technology. Researchers will now have access to specialized transgenic rats incorporating SBI's reagents, such as species-specific RNAi, MicroRNAs or anti-MicroRNAs. Rat models with inducible gene expression can also be produced using SBI's SparQ™ cumate switch system, the first inducible system that can be induced with a small molecule that can readily cross the blood-brain and blood-testis barriers.  "The combination of Transposagen and SBI's innovative technologies will now allow researchers to make sophisticated transgenic rat models that may mimic human diseases better than in the past," said Eric Ostertag, President and CEO of Transposagen.About Transposagen Biopharmaceuticals:Transposagen Biopharmaceuticals, Inc., a Lexington, KY-based company, is the worldwide leader in the creation of unique genetically modified rat models.  The company's signature products, TKO™ Knockout Rat Models and TGEM™ Rat Models, mimic human diseases and are used for drug discovery and development research. The company also creates custom transgenic rat models and custom knockout rat models to customer specifications. For more information or to request a custom rat model, visit www.transposagenbio.com.

    About System Biosciences (SBI):System Biosciences (SBI) specializes in developing unique, innovative technologies to provide researchers with the tools to investigate and understand genomic and proteomic function. SBI offers solutions for Lentiviral, Minicircle and piggyBac-mediated gene delivery and knockdown, high-throughput RNAi screens and products for Stem Cell and MicroRNA research. For more information, visit www.systembio.com.Transposagen Contact:System Biosciences Contact:Craig Morley

    Jake Lesnik201 East Main St. Suite 1405

    265 North Whisman Rd.Lexington, KY 40507

    Mountain View, CA 94043314-602-1993

    650-968-2200cmorley@transposagenbio.comjlesnik@systembio.comwww.transposagenbio.com

    www.systembio.com
    '/>"/>

    SOURCE Transposagen Biopharmaceuticals, Inc.; System Biosciences
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. BD and Diagenode Collaborate to Expand Infectious Disease Menu on the BD MAX™ System
    2. Image Sensing Systems Announces First Quarter Financial Results
    3. UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs
    4. Smart Systems Week in Helsinki June 14-17, 2011
    5. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
    6. Tomophase Announces First Sale of Its OCT Imaging System (OCTIS™) for Research Use to the University of Texas
    7. Conflict of Interest Management System Selected by Henry Ford Health System
    8. WaferGen and NuGEN Announce Agreement to Co-Develop Integrated Workflows Using SmartChip System and SPIA® for Single Cell Analysis, FFPE and Next Generation Sequencing
    9. Global HPLC Systems & Accessories Industry
    10. New Drug Delivery System to Improve Cancer Treatment
    11. Calipers Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
    (Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
    (Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
    Breaking Biology Technology:
    (Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
    (Date:6/9/2016)... -- Perkotek an innovation leader in attendance control systems is proud to announce the introduction ... to make sure the right employees are actually signing in, and to even control ... ... ... ...
    (Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
    Breaking Biology News(10 mins):